Skip to main content
Erschienen in: Techniques in Coloproctology 2/2013

01.04.2013 | Original Article

Video-assisted anal fistula treatment (VAAFT) combined with advancement flap repair in Crohn’s disease

verfasst von: O. Schwandner

Erschienen in: Techniques in Coloproctology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

It was the aim of this prospective study to analyze both the feasibility and preliminary results of video-assisted anal fistula treatment (VAAFT) combined with advancement flap repair for complex fistulas in Crohn's disease.

Methods

All patients with perianal Crohn's disease suffering from complex fistulas who underwent definitive surgery using VAAFT combined with advancement flap repair were prospectively enrolled in the study. Only complex fistulas with concurrent stable disease and without any evidence of severe inflammatory activity or perianal sepsis were treated using the VAAFT technique. Patients with Crohn's proctitis or prior proctectomy were not candidates for the procedure. VAAFT was performed by using the VAAFT equipment (Karl Storz, Tuttlingen, Germany). Key steps included visualization of the fistula tract and/or side tracts using the fistuloscope and correct localization of the internal fistula opening under direct vision with irrigation. Diagnostic fistuloscopy was followed by advancement flap repair. In addition to feasibility, primary end points included detection of side tracts, success and continence status (assessed by the Cleveland Clinic Incontinence Score). Success was defined as closure of both internal and external openings, absence of drainage without further intervention and absence of abscess formation. Follow-up information was derived from clinical examination 3, 6 and 9 months postoperatively.

Results

Within a 3-month observation period (September to November 2011), VAAFT was attempted in 13 patients with Crohn's associated complex fistulas. The completion rate was 85 % (11/13). In these 11 patients (median age 34 years, 64 % females), complex fistulas were transsphincteric (8), suprasphincteric (2) and recto-vaginal (1). Forty-six percent (5/11) had concomitant therapy with biologic drugs. In 36 % (4/11), VAAFT was performed with fecal diversion. Median duration of surgery was 22 (range 18–42) minutes. Using VAAFT, additional side tracts not detected preoperatively could be identified in 64 % (7/11). No morbidity occurred. After a mean follow-up of 9 months, the success rate was 82 % (9/11). No deterioration of continence was documented (Cleveland Clinic Incontinence Score 2.4 vs. 1.6, p > 0.05).

Conclusion

Preliminary results of the addition of the VAAFT technique to advancement flap repair in Crohn's fistulas demonstrate that this leads to a high identification rate of occult side tracts with encouraging short-term healing rates. Moreover, a completion rate of 85 % seems promising.
Literatur
1.
Zurück zum Zitat Mizrahi N, Wexner SD, Zmora O et al (2002) Endorectal advancement flap: are there predictors of failure? Dis Colon Rectum 45:1616–1621PubMedCrossRef Mizrahi N, Wexner SD, Zmora O et al (2002) Endorectal advancement flap: are there predictors of failure? Dis Colon Rectum 45:1616–1621PubMedCrossRef
2.
Zurück zum Zitat Sonoda T, Hull T, Piedmonte MR, Fazio VW (2002) Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap. Dis Colon Rectum 45:1622–1628PubMedCrossRef Sonoda T, Hull T, Piedmonte MR, Fazio VW (2002) Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap. Dis Colon Rectum 45:1622–1628PubMedCrossRef
3.
Zurück zum Zitat Löffler T, Welsch T, Mühl S, Hinz U, Schmidt J, Kinele P (2009) Long-term success rate after surgical treatment of anorectal and rectovaginal fistulas in Crohn's disease. Int J Colorectal Dis 24:521–526PubMedCrossRef Löffler T, Welsch T, Mühl S, Hinz U, Schmidt J, Kinele P (2009) Long-term success rate after surgical treatment of anorectal and rectovaginal fistulas in Crohn's disease. Int J Colorectal Dis 24:521–526PubMedCrossRef
4.
Zurück zum Zitat Meinero P, Mori L (2011) Video-assisted anal fistula treatment (VAAFT): a novel sphincter-saving procedure for treating complex anal fistulas. Tech Coloproctol 15:417–422PubMedCrossRef Meinero P, Mori L (2011) Video-assisted anal fistula treatment (VAAFT): a novel sphincter-saving procedure for treating complex anal fistulas. Tech Coloproctol 15:417–422PubMedCrossRef
5.
Zurück zum Zitat Hannaway CD, Hull TL (2008) Current considerations in the management of rectovaginal fistula from Crohn's disease. Colorectal Dis 10:747–755PubMedCrossRef Hannaway CD, Hull TL (2008) Current considerations in the management of rectovaginal fistula from Crohn's disease. Colorectal Dis 10:747–755PubMedCrossRef
6.
Zurück zum Zitat Andreani SM, Dang HH, Grondona P, Khan AZ, Edwards DP (2007) Rectovaginal fistula in Crohn’s disease. Dis Colon Rectum 50:2215–2222PubMedCrossRef Andreani SM, Dang HH, Grondona P, Khan AZ, Edwards DP (2007) Rectovaginal fistula in Crohn’s disease. Dis Colon Rectum 50:2215–2222PubMedCrossRef
7.
Zurück zum Zitat Joo JS, Weiss EG, Nogueras JJ, Wexner SD (1998) Endorectal advancement flap in perianal Crohn’s disease. Am Surg 64:147–150PubMed Joo JS, Weiss EG, Nogueras JJ, Wexner SD (1998) Endorectal advancement flap in perianal Crohn’s disease. Am Surg 64:147–150PubMed
8.
Zurück zum Zitat Schwandner O (2011) Obesity is a negative predictor of success after surgery for complex anal fistula. BMC Gastroenterol 11:61PubMedCrossRef Schwandner O (2011) Obesity is a negative predictor of success after surgery for complex anal fistula. BMC Gastroenterol 11:61PubMedCrossRef
9.
Zurück zum Zitat Jorge JM, Wexner SD (1993) Etiology and management of fecal incontinence. Dis Colon Rectum 36:77–97PubMedCrossRef Jorge JM, Wexner SD (1993) Etiology and management of fecal incontinence. Dis Colon Rectum 36:77–97PubMedCrossRef
10.
Zurück zum Zitat Tozer PJ, Burling D, Gupta A, Phillips RK, Hart AL (2011) Review article: medical, surgical and radiological management of perianal Crohn's fistulas. Aliment Pharmacol Ther 33:5–22PubMedCrossRef Tozer PJ, Burling D, Gupta A, Phillips RK, Hart AL (2011) Review article: medical, surgical and radiological management of perianal Crohn's fistulas. Aliment Pharmacol Ther 33:5–22PubMedCrossRef
11.
Zurück zum Zitat Bourikas LA, Koutroubakis IE (2010) Anti-TNF and fistulizing perianal Crohn's disease: use in clinical practice. Curr Drug Targets 11:187–197PubMedCrossRef Bourikas LA, Koutroubakis IE (2010) Anti-TNF and fistulizing perianal Crohn's disease: use in clinical practice. Curr Drug Targets 11:187–197PubMedCrossRef
12.
Zurück zum Zitat Karmiris K, Bielen D, Vanbeckevoort D et al (2011) Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging. Clin Gastroenterol Hepatol 9:130–136PubMedCrossRef Karmiris K, Bielen D, Vanbeckevoort D et al (2011) Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging. Clin Gastroenterol Hepatol 9:130–136PubMedCrossRef
13.
Zurück zum Zitat Bode M, Eder S, Schürmann G (2008) Perianal fistulas in Crohn's disease—biologicals and surgery: is it worthwhile? Z Gastroenterol 46:1376–1383PubMedCrossRef Bode M, Eder S, Schürmann G (2008) Perianal fistulas in Crohn's disease—biologicals and surgery: is it worthwhile? Z Gastroenterol 46:1376–1383PubMedCrossRef
14.
Zurück zum Zitat van der Hagen SJ, Baeten CG, Soeters PB, Russel MG, Beets-Tan RG, van Gemert WG (2005) Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report. Dis Colon Rectum 48:758–767PubMedCrossRef van der Hagen SJ, Baeten CG, Soeters PB, Russel MG, Beets-Tan RG, van Gemert WG (2005) Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report. Dis Colon Rectum 48:758–767PubMedCrossRef
15.
Zurück zum Zitat Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD (2006) Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum 49:1837–1841PubMedCrossRef Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD (2006) Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum 49:1837–1841PubMedCrossRef
16.
Zurück zum Zitat El-Gazzaz G, Hull T, Church JM (2012) Biological immunomodulators improve the healing rate in surgically treated perianal crohn's fistulas. Colorectal Dis 14:1217–1223PubMedCrossRef El-Gazzaz G, Hull T, Church JM (2012) Biological immunomodulators improve the healing rate in surgically treated perianal crohn's fistulas. Colorectal Dis 14:1217–1223PubMedCrossRef
17.
Zurück zum Zitat Schwandner O, Fuerst A, Kunstreich K, Scherer R (2009) Innovative technique for the closure of rectovaginal fistula using Surgisis mesh. Tech Coloproctol 13:135–140PubMedCrossRef Schwandner O, Fuerst A, Kunstreich K, Scherer R (2009) Innovative technique for the closure of rectovaginal fistula using Surgisis mesh. Tech Coloproctol 13:135–140PubMedCrossRef
18.
Zurück zum Zitat Sciaudone G, Di Stazio C, Limongelli P et al (2010) Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach. Can J Surg 53:299–304PubMed Sciaudone G, Di Stazio C, Limongelli P et al (2010) Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach. Can J Surg 53:299–304PubMed
19.
Zurück zum Zitat Duff S, Sagar PM, Rao M, Dolling S, Sprakes M, Hamlin PJ (2011) Infliximab and surgical treatment of complex anal Crohn's disease. Colorectal Dis 14:972–976CrossRef Duff S, Sagar PM, Rao M, Dolling S, Sprakes M, Hamlin PJ (2011) Infliximab and surgical treatment of complex anal Crohn's disease. Colorectal Dis 14:972–976CrossRef
Metadaten
Titel
Video-assisted anal fistula treatment (VAAFT) combined with advancement flap repair in Crohn’s disease
verfasst von
O. Schwandner
Publikationsdatum
01.04.2013
Verlag
Springer Milan
Erschienen in
Techniques in Coloproctology / Ausgabe 2/2013
Print ISSN: 1123-6337
Elektronische ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-012-0921-7

Weitere Artikel der Ausgabe 2/2013

Techniques in Coloproctology 2/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.